Also, a majority of these tumors are benign, though 1 in 10 may be malignant
How to spot misleading GLP-1 patch marketing Red flags: any claim of containing "semaglutide" or "tirzepatide" (illegal without a prescription), before-and-after photos without clinical trial context, specific weight-loss promises ("lose 12+ lbs per month"), language like "Nature's Ozempic" or "works like Wegovy," and any implication of FDA review
Instruct patients to inform all health care providers, including the preprocedure assessment team and the anesthesiologist, about their use of GLP-1 receptor agonists, and suggest that they proactively ask for recommendations to reduce the risk of aspiration
It meets modern expectations of care, offering a unique blend of convenience, safety, and personalization.